Best Probiotics for Dogs with a Yeast Infection – An Evidence Based Guide

Summary

Yeast infections in dogs, caused by overgrowth of the commensal fungus Malassezia pachydermatis, affect the skin, ears and paws and are almost always secondary to an underlying problem, most often allergic dermatitis. This guide identifies which probiotic strains have genuine canine evidence for the skin conditions that drive yeast overgrowth, explains the gut-skin axis mechanisms that make them work, and sets out realistic dosing and timelines. It goes beyond surface advice to the biochemistry of short-chain fatty acid production, epigenetic regulation, immune programming and direct antifungal action, so strain selection and expectations are grounded in how these interventions actually behave in the body.

Probiotics and Yeast Infections in Dogs: What the Evidence Shows

Malassezia pachydermatis is a normal resident of canine skin, ears and muco-cutaneous junctions. It causes problems only when the balance that keeps it in check breaks down, and that breakdown is usually secondary to allergic disease, medication effects, endocrine disorders or barrier dysfunction. Because the most common trigger is atopic dermatitis, the strongest lever for recurrent yeast is not the fungus itself but the gut and immune terrain that permits it.

That is where probiotics earn their place. Multiple canine trials show probiotic supplementation reduces the clinical signs of atopic dermatitis,²ʼ³ʼ⁵ and research now documents the gut-skin axis directly in dogs.⁶ʼ⁷ This article explains the mechanisms in plain terms and in depth, then names the strains with real canine evidence so you can choose on substance rather than marketing.

Key Takeaways

• Probiotics reduce the signs of the disease that drives yeast. Canine trials show probiotic supplementation lowers clinical severity in atopic dermatitis, the condition most often complicated by secondary Malassezia overgrowth.²ʼ³ʼ⁵
• The gut-skin axis is measurable in dogs. Dogs with atopic dermatitis have significantly lower faecal short-chain fatty acid concentrations and altered gut microbiome composition than healthy dogs.⁶ʼ⁷
• Mechanism explains method. Short-chain fatty acid production, HDAC inhibition, immune programming and receptor signalling explain why strain selection and prebiotic co-administration matter.
• Strain selection is not arbitrary. EFSA-authorised Bacillus velezensis (Calsporin®) and well-researched Lactobacillus rhamnosus have the strongest canine evidence base.⁸ʼ⁹
• Consistency wins. Trials showing benefit use 8 to 16 weeks of continuous supplementation.²ʼ³

Clinical Insight: Recurrent yeast infections signal an underlying condition that needs investigation. Malassezia dermatitis is almost always secondary to allergic disease, immune dysfunction or endocrine disorders,⁴ so probiotics are one component of management, not a replacement for diagnosing the root cause.

This article is part of Bonza’s probiotics series. For the full overview of strains, regulatory status and condition applications, see Best Probiotics for Dogs: Canine Nutritionist’s Guide to Real Results.

---

In This Guide

• Understanding Yeast Infections in Dogs
• The Gut-Skin Axis: From Intestine to Integument
• The Biochemistry of Probiotic Action
• Evidence-Based Strain Selection
• How to Choose and Use Probiotics
• Complementary Nutritional Strategies
• What to Expect: Supplementation Timeline
• Frequently Asked Questions
• Conclusion
• References
• Editorial Information

Understanding Yeast Infections in Dogs

What Causes Yeast Infections in Dogs?

Yeast overgrowth begins when something disrupts the balance that normally keeps Malassezia in low numbers. Malassezia pachydermatis is lipophilic and lives quietly in the ear canals, skin folds and muco-cutaneous junctions of healthy dogs as part of the normal flora. Problems arise when the terrain shifts in its favour. Contributing factors include:

• Allergic disease: canine atopic dermatitis and food allergies are the most common underlying causes. Inflammation and a compromised skin barrier create conditions that favour yeast proliferation.
• Medications: antibiotics disrupt microbiome balance; corticosteroids and other immunosuppressants reduce immune surveillance.
• Endocrine disorders: hypothyroidism and hyperadrenocorticism (Cushing’s disease) alter skin immunity and sebum composition.
• Moisture: warm, damp sites (ears, interdigital spaces, skin folds) provide ideal conditions.
• Skin barrier dysfunction: anything that compromises the physical or chemical barriers of the skin can permit overgrowth.

What Are the Symptoms of a Yeast Infection in Dogs?

The hallmark signs are itch, redness and a distinctive odour. Common signs include intense itching and scratching (often worse than the visible lesions suggest), erythema in skin folds, ear canals and between the toes, a musty or “cheesy” smell, greasy or waxy skin and ear discharge, thickened “elephant” skin (lichenification) and darkening (hyperpigmentation) in chronic cases, and hair loss secondary to self-trauma.

The Gut-Skin Axis: From Intestine to Integument

In Plain English

Your dog’s gut and skin are in constant conversation. Bacteria in the intestine produce chemical messengers that travel through the bloodstream and influence how skin functions, including its ability to keep yeast in check. When gut health is compromised, skin health often follows. This is not metaphor; it is measurable biochemistry.

The Science: A Bidirectional Communication Network

The gut-skin axis describes the two-way signalling network connecting intestinal microbiota with skin physiology, operating through several channels:

1. Circulating metabolites. Gut bacteria produce metabolites (short-chain fatty acids, tryptophan derivatives, polyamines) that enter systemic circulation and reach the skin, where they influence keratinocyte differentiation, sebocyte function and local immune responses.

2. Immune cell trafficking. Immune cells primed in gut-associated lymphoid tissue do not stay in the gut. A regulatory T cell educated in the Peyer’s patches of the small intestine can later appear in the dermis, carrying its tolerogenic programming with it.

3. Systemic inflammatory tone. When gut barrier integrity is compromised, bacterial components such as lipopolysaccharide enter circulation. Even low-level translocation triggers a chronic, low-grade inflammatory state that affects every organ system, including skin.

Evidence in Dogs

Research on the gut-skin axis in dogs has accelerated. A 2026 study in Veterinary Dermatology measured faecal short-chain fatty acid concentrations in dogs with atopic dermatitis versus healthy controls, and found significantly lower acetic, propionic and butyric acid in affected dogs.⁶ These are fundamental alterations in gut metabolic output, not subtle differences. Microbiome studies add to the picture: dogs with atopic dermatitis consistently show reduced bacterial diversity and lower abundance of short-chain fatty acid producers.⁷

Since atopic dermatitis is the most common underlying cause of Malassezia overgrowth, these findings give a mechanistic link: compromised gut, reduced short-chain fatty acid production, impaired barrier and immune regulation, and a permissive environment for yeast.

Why This Matters

Treating yeast with topical antifungals alone addresses the symptom, not the terrain that permitted it. Supporting gut health with probiotics is an attempt to modify that terrain at a fundamental level. To rebalance the microbiome during yeast overgrowth, a multi-strain approach helps: Bonza’s gut microbiome and immunity supplement combines a resilient probiotic with prebiotic and postbiotic support. For how the gut ecosystem keeps opportunistic yeast in check, see The Dog Gut Microbiome: Vital Key to Dog Health, and for the skin side of the axis, The Gut-Skin Axis in Dogs: Why Skin Problems Start in the Gut.

The Biochemistry of Probiotic Action

Understanding how probiotics work, not just that they work, enables rational strain selection and realistic expectations.

Mechanism 1: Short-Chain Fatty Acid Production

In Plain English. Beneficial bacteria ferment fibre into short-chain fatty acids, mainly acetate, propionate and butyrate. These are signalling molecules that fuel gut cells, seal the intestinal barrier, reduce inflammation and communicate with distant organs including skin. Butyrate alone provides roughly 60 to 70 percent of the energy used by the cells lining the colon.¹⁶

The Science. Homofermentative lactobacilli use the glycolytic pathway to produce lactate; heterofermentative species use the phosphoketolase pathway for a mix of lactate, acetate, ethanol and CO₂; bifidobacteria use the bifid shunt to yield acetate and lactate in a 3:2 ratio. Dedicated butyrate producers convert acetate and lactate to butyrate, a cross-feeding relationship that explains why diverse microbiomes produce more butyrate than monocultures. The resulting short-chain fatty acids appear in approximate molar ratios of 60:20:20 (acetate:propionate:butyrate).

Butyrate’s importance exceeds its proportion. Colonocytes preferentially oxidise butyrate, deriving roughly 60 to 70 percent of their energy from it,¹⁶ which powers the pumps that maintain nutrient absorption, consumes oxygen at the epithelial surface (favouring beneficial anaerobes), and prevents the barrier-degrading autophagy that butyrate-starved colonocytes undergo. Acetate and propionate enter portal circulation, with acetate reaching peripheral tissues including skin.

Why This Matters. Prebiotic co-administration enhances efficacy, since bacteria cannot produce short-chain fatty acids without fermentable substrate; strain diversity supports the cross-feeding that maximises butyrate; and a diet devoid of fermentable fibre undermines probiotic benefit regardless of strain quality or CFU count.

Mechanism 2: Epigenetic Regulation via HDAC Inhibition

In Plain English. Butyrate influences which genes switch on or off. It blocks histone deacetylase enzymes that normally keep certain genes silenced, so genes involved in reducing inflammation and strengthening barriers become more active. This is not a drug effect; it is how the body is designed to respond to signals from beneficial bacteria.

The Science. DNA wraps around histones; how tightly it wraps determines whether genes can be transcribed. Histone acetylation relaxes chromatin and permits transcription; histone deacetylases remove acetyl groups and re-silence genes. At physiological colonic concentrations, butyrate is a competitive HDAC inhibitor. This upregulates tight junction proteins (claudin-1, occludin, ZO-1), the mucin MUC2, anti-inflammatory IL-10 (with reduced NF-κB activity) and antimicrobial peptides. Circulating butyrate reaches keratinocytes, where it promotes differentiation and upregulates filaggrin, a barrier protein whose deficiency is implicated in atopic dermatitis.¹¹

Why This Matters. Epigenetic remodelling takes time, which is why trials show optimal benefit at 8 to 16 weeks rather than days; effects can outlast the organisms themselves, consistent with canine research where Lactobacillus rhamnosus benefits remained detectable three years after supplementation ended;¹⁰ and the barrier effects occur in both gut epithelium and skin keratinocytes, a molecular basis for gut-skin communication.

Mechanism 3: Immune Modulation via Gut-Associated Lymphoid Tissue

In Plain English. A large share of your dog’s immune cells reside in the gut. Probiotics help “educate” these cells to respond appropriately, neither underreacting to genuine threats nor overreacting to harmless substances. That education does not stay in the gut; trained immune cells travel throughout the body, including to the skin.

The Science. The intestinal immune system samples luminal contents through M cells and dendritic cells. The context in which dendritic cells meet an antigen determines the response they induce, and probiotic components and metabolites bias dendritic cells toward tolerogenic programming: they upregulate CD103, produce retinoic acid and TGF-β, and preferentially induce Foxp3⁺ regulatory T cells that produce IL-10 and TGF-β. Probiotics also enhance secretory IgA, which binds microbes in the lumen without triggering inflammation. Crucially, a subset of gut-primed regulatory T cells upregulate skin-homing receptors and migrate to cutaneous sites, so a cell programmed in the Peyer’s patches can later suppress inflammation in the dermis.

Why This Matters. Oral probiotics influence immune responses body-wide, including skin, with no topical application required; they promote regulated tolerance rather than generalised stimulation, which is exactly what allergic overreaction needs; and early-life exposure may have lasting effects, consistent with canine research showing reduced allergic sensitisation that persisted into adulthood.⁹ʼ¹⁰

Mechanism 4: pH Modification and Direct Antifungal Effects

In Plain English. Probiotic bacteria produce lactic and other organic acids that lower local pH. Malassezia prefers slightly alkaline conditions, so acidity inhibits it, and some probiotics produce compounds that directly damage fungal cells. This is competitive exclusion at a chemical level.

The Science. Lactic acid’s undissociated form is lipophilic, crosses microbial membranes and acidifies the cytoplasm, disrupting enzyme function. Malassezia grows optimally at pH 5.5 to 7.5 and is inhibited below 4.5, concentrations achievable in the microenvironment at the epithelial surface. Probiotics also produce bacteriocins, biosurfactants, hydrogen peroxide and short-chain fatty acids with antifungal activity. Saccharomyces boulardii is a special case: this probiotic yeast produces capric acid that inhibits Candida germ-tube formation, biofilm formation and adhesion,¹⁴ and competes for nutrients and attachment sites without colonising permanently.

Why This Matters. Antimicrobial output is strain-specific, so selecting strains with documented antifungal activity beats generic “probiotic” products. Because S. boulardii is a living yeast, it should not be given alongside systemic antifungal drugs. And pH effects are local: the relevance for skin yeast is indirect, via gut immune and metabolic effects, not direct action at the skin.

Mechanism 5: Short-Chain Fatty Acid Receptor Signalling

In Plain English. Your dog’s cells carry receptors that detect short-chain fatty acids like a lock and key. When these bind, they trigger cascades that make immune cells less inflammatory, prompt gut cells to produce more mucus, and shift metabolism. This is how bacterial metabolites talk to host cells.

The Science. Three receptors act as primary sensors: GPR43 (acetate, propionate), GPR41 (propionate, butyrate) and GPR109A (butyrate). GPR43 activation on immune cells reduces reactive oxygen species and inflammatory cytokines, impairs dendritic cell maturation, and enhances regulatory T cell differentiation. GPR109A promotes regulatory T cell induction and is expressed in skin, where activation may influence barrier and inflammatory responses. Receptor signalling also suppresses NF-κB, dampens NLRP3 inflammasome activation and activates PPARγ.

Why This Matters. Receptor expression varies by tissue, so effects are tissue-specific; activation requires sufficient concentrations, so subtherapeutic doses or inadequate prebiotic substrate may fall short; and these receptors are conserved across mammals, so rodent and human findings translate reasonably to dogs.

Evidence-Based Strain Selection

In Plain English. Not all probiotics are equal. What works for human digestion may not suit canine skin conditions. The strains below have the strongest evidence for dogs with skin issues or yeast susceptibility.

1. Bacillus velezensis DSM 15544 (Calsporin®)

This EFSA-authorised spore-forming probiotic has undergone formal safety and efficacy assessment for dogs, with EFSA concluding it is safe and effective as a gut flora stabiliser.⁸ (Note: DSM 15544 was originally classified as Bacillus subtilis and later reclassified as Bacillus velezensis, so older sources may list either name.) As a spore-former, it survives gastric acid, bile and kibble extrusion, then germinates in the lower intestine, achieving very high survival through gastric transit where many non-spore-forming probiotics do not.

2. Lactobacillus rhamnosus GG

University of Florida research provides the strongest canine case for early-life intervention in atopy-prone dogs. Puppies given L. rhamnosus GG from three weeks to six months showed significantly lower allergen-specific IgE, fewer positive intradermal reactions and partial protection against atopic dermatitis versus littermates.⁹ A follow-up three years after supplementation ended found persistent benefit, with probiotic-exposed dogs still showing significantly lower clinical scores after allergen challenge,¹⁰ consistent with the epigenetic and immune-programming mechanisms above.

3. Lactobacillus acidophilus with Bifidobacterium bifidum

A 2025 study in BMC Microbiology gave dogs with atopic dermatitis a combination of B. bifidum, L. acidophilus and Enterococcus faecium daily for 16 weeks, with significant improvement in CADESI-4 (clinical severity) and PVAS (owner-assessed pruritus) scores and increased gut microbiota diversity.² The study also noted that dogs with more severe disease had higher baseline Lactobacillus and Bifidobacterium, a reminder that more is not always better.

4. Saccharomyces boulardii

This beneficial yeast is naturally resistant to antibacterial antibiotics, does not colonise permanently, and competes directly with pathogenic yeasts. A canine study demonstrated safety and tolerability in dogs with chronic enteropathy;¹³ while that trial was gastrointestinal rather than dermatological, it establishes feasibility of supplementation in dogs. Its antifungal mechanisms (capric acid inhibiting Candida adhesion and hyphal formation, biofilm disruption, immune modulation) are well characterised from human and in vitro work¹⁴ and are expected to translate to Malassezia given conserved yeast biology, though direct anti-Malassezia canine studies are not yet published. Caution: as a living yeast, do not give S. boulardii alongside ketoconazole, itraconazole, fluconazole or similar drugs.

5. Lactobacillus paracasei K71

A Japanese trial compared K71 against the antihistamine cetirizine in 41 dogs with mild-to-moderate atopic dermatitis over 12 weeks. Both groups improved and there was no statistically significant difference between them, placing probiotic performance in a comparable therapeutic range to a conventional antihistamine, with the safety advantages of a probiotic.⁵

---

How To Choose and Use Probiotics for Yeast Infections

---

Complementary Nutritional Strategies

Foods to include: low-glycaemic vegetables (green beans, broccoli, leafy greens); omega-3 sources (algae oil, flaxseed) for anti-inflammatory support and barrier function; prebiotic fibres (chicory inulin/FOS, yeast-derived MOS); and high-quality plant proteins (lentils, chickpeas, peas).

Foods to minimise: high-glycaemic ingredients, highly processed treats, and known allergens where food allergy contributes to the underlying condition.

Topical and natural support: for active infections, veterinary antifungal shampoos (2% miconazole, 2% ketoconazole, 2% chlorhexidine, or combinations) are typically more effective than natural alternatives.⁴ Coconut oil offers medium-chain fatty acids with antifungal properties; diluted apple cider vinegar (1:1) as a rinse may help restore skin pH, but avoid it on broken or inflamed skin.

What to Expect: Probiotic Supplementation Timeline

Microbiome rebalancing does not happen overnight. This timeline reflects canine clinical-trial data and the underlying biology.

• Week 1 to 2 (adjustment): organisms establish; mild digestive changes are normal; little visible skin change yet.
• Week 2 to 4 (early metabolic): short-chain fatty acid production rises and barrier genes begin upregulating; some dogs show early improvement, many do not yet. The 2024 randomised controlled trial by Tate et al. found probiotic-supplemented dogs showed greater improvement in owner-assessed pruritus than placebo, with modest early differences.³
• Week 4 to 8 (immune modulation): regulatory T cells enter circulation, IgA rises, inflammatory tone shifts; more consistent improvement in scratching, redness and coat. The L. paracasei K71 trial showed meaningful improvement by 12 weeks, comparable to antihistamine treatment.⁵
• Week 8 to 16 (optimal rebalancing): maximum benefit is typically reached; skin is noticeably improved and ear infections, if present, are less frequent. Song et al. (2025) showed significant CADESI-4 and PVAS improvement after 16 weeks alongside measurable gains in gut microbiota diversity.²
• Week 16 and beyond (maintenance): the goal shifts to holding the improved state. Epigenetic changes persist, but without continued prebiotic substrate and reinforcement the microbiome can drift back, particularly under stress, illness or antibiotic use.

When to reassess: consult your vet if there is no improvement after eight weeks with appropriate strains and adequate prebiotic support, if symptoms worsen, or if you are unsure whether underlying conditions have been addressed.

---

Timeline Summary Table

Phase	Timeframe	Key Processes	Expected Outcome
Adjustment	Week 1-2	Colonisation, initial fermentation	Possible mild GI changes; no skin improvement expected
Early Metabolic	Week 2-4	SCFA production ↑, barrier gene expression begins	Some dogs show early improvement; many unchanged
Immune Modulation	Week 4-8	Treg induction, IgA ↑, inflammatory tone ↓	Consistent improvement in most responders
Optimal Rebalancing	Week 8-16	Full microbiome restructuring, epigenetic consolidation	Maximum benefit; significant clinical improvement
Maintenance	Week 16+	Sustaining improved state	Continued supplementation or reduced maintenance dose

---

This timeline represents typical responses based on clinical trial data. Individual dogs vary—some respond faster, others slower. Underlying conditions, diet, concurrent medications, and baseline microbiome status all influence outcomes.

---

Frequently Asked Questions

---

Conclusion

The link between gut health and skin conditions rests on solid biochemistry. Short-chain fatty acids from beneficial bacteria fuel colonocytes, seal the intestinal barrier through epigenetic upregulation of tight junction proteins, modulate immune responses, and circulate to influence distant organs including skin. For dogs with yeast infections, conditions almost always secondary to underlying immune or barrier dysfunction, supporting gut health with evidence-based probiotics is a rational, mechanism-supported intervention. It is not alternative medicine; it is applied microbiology.

Probiotics are not a standalone fix. Effective management means identifying and treating underlying conditions, using appropriate antifungal therapy for active infections, supplementing consistently with canine-evidenced strains, adjusting diet to support fermentation, and holding realistic timelines. One Gut. Whole Dog. is the principle at work here: fix the gut terrain and the skin follows.

Related Articles

• Best Probiotics for Dogs: Canine Nutritionist’s Guide to Real Results
• Best Prebiotics for Dogs: Canine Nutritionist’s Complete Guide
• The Gut-Skin Axis in Dogs: Why Skin Problems Start in the Gut
• The Dog Gut Microbiome: Vital Key to Dog Health

Why Bonza: Synbiotic Support for Yeast-Prone Dogs

Bonza Superfoods & Ancient Grains includes Calsporin® (Bacillus velezensis DSM 15544), one of only two bacterial probiotics with full EFSA authorisation for dogs, alongside PHYTOPLUS®, our 28-ingredient bioactive blend, and the postbiotic TruPet™ for immediate receptor-level signalling. For skin-specific support, Block Bioactive Bites combines pre-, pro- and postbiotics with natural antihistamines (quercetin, nettle), omega fatty acids, zinc, and boswellia and turmeric for NF-κB modulation, designed to support dogs prone to itchy skin, allergies and recurrent yeast issues as part of comprehensive management.

References

1. Suchodolski JS. Intestinal microbiota of dogs and cats: a bigger world than we thought. Vet Clin North Am Small Anim Pract. 2011;41(2):261-272. doi: 10.1016/j.cvsm.2010.12.006. PMID: 21486635. PMC: PMC7132526.
2. Song H, Mun SH, Han DW, Kang JH, An JU, Hwang CY, Cho S. Probiotics ameliorate atopic dermatitis by modulating the dysbiosis of the gut microbiota in dogs. BMC Microbiol. 2025;25(1):228. doi: 10.1186/s12866-025-03924-6. PMID: 40264044. PMC: PMC12012994.
3. Tate DE, Tanprasertsuk J, Jones RB, Maughan H, Chakrabarti A, Khafipour E, Norton SA, Shmalberg J, Honaker RW. A randomized controlled trial to evaluate the impact of a novel probiotic and nutraceutical supplement on pruritic dermatitis and the gut microbiota in privately owned dogs. Animals (Basel). 2024;14(3):453. doi: 10.3390/ani14030453. PMID: 38338095. PMC: PMC10854619.
4. Bajwa J. Canine Malassezia dermatitis. Can Vet J. 2017;58(10):1119-1121. PMID: 28966366. PMC: PMC5603939.
5. Ohshima-Terada Y, Higuchi Y, Kumagai T, Hagihara A, Nagata M. Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis. Vet Dermatol. 2015;26(5):350-353, e74-e75. doi: 10.1111/vde.12224. PMID: 26123498.
6. Gonçalves M, Fernandes B, Alves SP, Pereira H, Prego MT, Lourenço AM. Preliminary measurement of faecal short-chain fatty acids in dogs with canine atopic dermatitis. Vet Dermatol. 2026;37(1):45-50. doi: 10.1111/vde.70015. PMID: 41527507.
7. Rostaher A, Morsy Y, Favrot C, Unterer S, Schnyder M, Scharl M, Fischer NM. Comparison of the gut microbiome between atopic and healthy dogs: preliminary data. Animals (Basel). 2022;12(18):2377. doi: 10.3390/ani12182377. PMID: 36139237. PMC: PMC9495170.
8. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Safety and efficacy of Calsporin® (Bacillus subtilis DSM 15544) as a feed additive for dogs. EFSA Journal. 2017;15(4):4760. doi: 10.2903/j.efsa.2017.4760.
9. Marsella R. Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs. Am J Vet Res. 2009;70(6):735-740. doi: 10.2460/ajvr.70.6.735. PMID: 19496662.
10. Marsella R, Santoro D, Ahrens K. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects. Vet Immunol Immunopathol. 2012;146(2):185-189. doi: 10.1016/j.vetimm.2012.02.013. PMID: 22436376.
11. Trompette A, Pernot J, Perdijk O, Alqahtani RAA, Domingo JS, Camacho-Muñoz D, Wong NC, Kendall AC, Wiederkehr A, Nicod LP, Nicolaou A, von Garnier C, Ubags NDJ, Marsland BJ. Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation. Mucosal Immunol. 2022;15(5):908-926. doi: 10.1038/s41385-022-00524-9. PMID: 35672452. PMC: PMC9385498.
12. Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics: what is the evidence? Vet Med Sci. 2016;2(2):71-94. doi: 10.1002/vms3.17. PMID: 29067182. PMC: PMC5645859.
13. D’Angelo S, Fracassi F, Bresciani F, Galuppi R, Diana A, Linta N, Bettini G, Morini M, Pietra M. Effect of Saccharomyces boulardii in dogs with chronic enteropathies: double-blinded, placebo-controlled study. Vet Rec. 2018;182(9):258. doi: 10.1136/vr.104241. PMID: 29212912.
14. Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One. 2010;5(8):e12050. doi: 10.1371/journal.pone.0012050. PMID: 20706577. PMC: PMC2919387.
15. Kim H, Rather IA, Kim H, Kim S, Kim T, Jang J, Seo J, Lim J, Park YH. A double-blind, placebo-controlled trial of a probiotic strain Lactobacillus sakei Probio-65 for the prevention of canine atopic dermatitis. J Microbiol Biotechnol. 2015;25(11):1966-1969. doi: 10.4014/jmb.1506.06065. PMID: 26282691.
16. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21(9):793-798. doi: 10.1136/gut.21.9.793. PMID: 7429343. PMC: PMC1419334.

Editorial Information

Field	Detail
Published	January 2025
Last Updated	July 2026
Reviewed by	Bonza Veterinary Advisory Board
Next Review	January 2027
Author	Glendon Lloyd, Dip. Canine Nutrition (Dist.), Dip. Dog Nutrigenomics (Dist.)
Disclaimer	This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen.